nodes	percent_of_prediction	percent_of_DWPC	metapath
Busulfan—Alkylating Activity—Ifosfamide—testicular cancer	0.312	0.529	CiPCiCtD
Busulfan—Alkylating Activity—Chlorambucil—testicular cancer	0.278	0.471	CiPCiCtD
Busulfan—GSTP1—Chlorambucil—testicular cancer	0.11	0.364	CbGbCtD
Busulfan—GSTM1—Carboplatin—testicular cancer	0.0493	0.162	CbGbCtD
Busulfan—GSTM1—Cisplatin—testicular cancer	0.0421	0.139	CbGbCtD
Busulfan—GSTP1—Carboplatin—testicular cancer	0.0357	0.117	CbGbCtD
Busulfan—GSTP1—Cisplatin—testicular cancer	0.0305	0.1	CbGbCtD
Busulfan—GSTP1—Etoposide—testicular cancer	0.0299	0.0986	CbGbCtD
Busulfan—CYP3A4—Ifosfamide—testicular cancer	0.00246	0.00809	CbGbCtD
Busulfan—MGST2—Glutathione conjugation—HPGDS—testicular cancer	0.00189	0.102	CbGpPWpGaD
Busulfan—GSTA1—Glutathione conjugation—HPGDS—testicular cancer	0.00161	0.0865	CbGpPWpGaD
Busulfan—GSTA1—embryo—testicular cancer	0.00155	0.103	CbGeAlD
Busulfan—MGST2—NRF2 pathway—SLC2A6—testicular cancer	0.00155	0.0832	CbGpPWpGaD
Busulfan—GSTA1—NRF2 pathway—SLC2A6—testicular cancer	0.00132	0.0708	CbGpPWpGaD
Busulfan—CYP3A4—Vinblastine—testicular cancer	0.0013	0.00429	CbGbCtD
Busulfan—MGST2—Podofilox—Etoposide—testicular cancer	0.00126	1	CbGdCrCtD
Busulfan—CYP3A4—Etoposide—testicular cancer	0.00117	0.00386	CbGbCtD
Busulfan—GSTA2—embryo—testicular cancer	0.00112	0.0743	CbGeAlD
Busulfan—GSTA2—Glutathione conjugation—HPGDS—testicular cancer	0.00109	0.0584	CbGpPWpGaD
Busulfan—GSTM1—Glutathione conjugation—HPGDS—testicular cancer	0.00106	0.0568	CbGpPWpGaD
Busulfan—GSTA1—gonad—testicular cancer	0.00105	0.0698	CbGeAlD
Busulfan—MGST2—female gonad—testicular cancer	0.00101	0.0668	CbGeAlD
Busulfan—GSTP1—Glutathione conjugation—HPGDS—testicular cancer	0.000899	0.0483	CbGpPWpGaD
Busulfan—MGST2—testis—testicular cancer	0.000893	0.0592	CbGeAlD
Busulfan—GSTA2—NRF2 pathway—SLC2A6—testicular cancer	0.000889	0.0478	CbGpPWpGaD
Busulfan—GSTM1—NRF2 pathway—SLC2A6—testicular cancer	0.000865	0.0465	CbGpPWpGaD
Busulfan—GSTA1—female gonad—testicular cancer	0.000856	0.0568	CbGeAlD
Busulfan—MGST2—Phase II conjugation—HPGDS—testicular cancer	0.000842	0.0453	CbGpPWpGaD
Busulfan—CYP3A4—Doxorubicin—testicular cancer	0.0008	0.00264	CbGbCtD
Busulfan—GSTM1—gonad—testicular cancer	0.000779	0.0517	CbGeAlD
Busulfan—GSTA2—gonad—testicular cancer	0.00076	0.0504	CbGeAlD
Busulfan—GSTA1—testis—testicular cancer	0.000759	0.0503	CbGeAlD
Busulfan—GSTP1—NRF2 pathway—SLC2A6—testicular cancer	0.000735	0.0395	CbGpPWpGaD
Busulfan—GSTP1—embryo—testicular cancer	0.000719	0.0477	CbGeAlD
Busulfan—GSTA1—Phase II conjugation—HPGDS—testicular cancer	0.000716	0.0385	CbGpPWpGaD
Busulfan—GSTP1—seminal vesicle—testicular cancer	0.000675	0.0448	CbGeAlD
Busulfan—MGST2—lymph node—testicular cancer	0.000647	0.0429	CbGeAlD
Busulfan—GSTM1—female gonad—testicular cancer	0.000633	0.042	CbGeAlD
Busulfan—GSTA2—female gonad—testicular cancer	0.000618	0.041	CbGeAlD
Busulfan—GSTM1—testis—testicular cancer	0.000561	0.0372	CbGeAlD
Busulfan—GSTA2—testis—testicular cancer	0.000548	0.0363	CbGeAlD
Busulfan—GSTM1—C-MYB transcription factor network—MAD1L1—testicular cancer	0.000512	0.0275	CbGpPWpGaD
Busulfan—MGST2—Biological oxidations—HPGDS—testicular cancer	0.000493	0.0265	CbGpPWpGaD
Busulfan—GSTP1—gonad—testicular cancer	0.000488	0.0324	CbGeAlD
Busulfan—GSTA2—Phase II conjugation—HPGDS—testicular cancer	0.000484	0.026	CbGpPWpGaD
Busulfan—GSTM1—Phase II conjugation—HPGDS—testicular cancer	0.000471	0.0253	CbGpPWpGaD
Busulfan—GSTA1—Biological oxidations—HPGDS—testicular cancer	0.000419	0.0225	CbGpPWpGaD
Busulfan—GSTM1—lymph node—testicular cancer	0.000407	0.027	CbGeAlD
Busulfan—GSTP1—Phase II conjugation—HPGDS—testicular cancer	0.0004	0.0215	CbGpPWpGaD
Busulfan—GSTP1—female gonad—testicular cancer	0.000397	0.0263	CbGeAlD
Busulfan—GSTM1—C-MYB transcription factor network—H2AFZ—testicular cancer	0.000357	0.0192	CbGpPWpGaD
Busulfan—GSTP1—testis—testicular cancer	0.000352	0.0233	CbGeAlD
Busulfan—GSTM1—C-MYB transcription factor network—KITLG—testicular cancer	0.000328	0.0177	CbGpPWpGaD
Busulfan—GSTA2—Biological oxidations—HPGDS—testicular cancer	0.000283	0.0152	CbGpPWpGaD
Busulfan—GSTM1—Biological oxidations—HPGDS—testicular cancer	0.000275	0.0148	CbGpPWpGaD
Busulfan—GSTP1—lymph node—testicular cancer	0.000255	0.0169	CbGeAlD
Busulfan—GSTP1—Biological oxidations—HPGDS—testicular cancer	0.000234	0.0126	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—KIT—testicular cancer	0.000224	0.012	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—H2AFZ—testicular cancer	0.000121	0.00653	CbGpPWpGaD
Busulfan—MGST2—Metabolism—HPGDS—testicular cancer	8.43e-05	0.00453	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—HPGDS—testicular cancer	7.17e-05	0.00385	CbGpPWpGaD
Busulfan—MGST2—Metabolism—STK11—testicular cancer	6.12e-05	0.00329	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—STK11—testicular cancer	5.21e-05	0.0028	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—HPGDS—testicular cancer	4.84e-05	0.0026	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—HPGDS—testicular cancer	4.71e-05	0.00253	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—HPGDS—testicular cancer	4e-05	0.00215	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—STK11—testicular cancer	3.52e-05	0.00189	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—STK11—testicular cancer	3.42e-05	0.00184	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—HPGDS—testicular cancer	3.32e-05	0.00179	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—STK11—testicular cancer	2.91e-05	0.00156	CbGpPWpGaD
Busulfan—Fatigue—Etoposide—testicular cancer	2.65e-05	0.000368	CcSEcCtD
Busulfan—Stomatitis—Epirubicin—testicular cancer	2.63e-05	0.000365	CcSEcCtD
Busulfan—Jaundice—Epirubicin—testicular cancer	2.63e-05	0.000365	CcSEcCtD
Busulfan—Pain—Etoposide—testicular cancer	2.63e-05	0.000365	CcSEcCtD
Busulfan—Constipation—Etoposide—testicular cancer	2.63e-05	0.000365	CcSEcCtD
Busulfan—Neutropenia—Doxorubicin—testicular cancer	2.62e-05	0.000364	CcSEcCtD
Busulfan—Dysuria—Doxorubicin—testicular cancer	2.62e-05	0.000364	CcSEcCtD
Busulfan—Haemoglobin—Methotrexate—testicular cancer	2.6e-05	0.000361	CcSEcCtD
Busulfan—Haemorrhage—Methotrexate—testicular cancer	2.59e-05	0.00036	CcSEcCtD
Busulfan—Haematuria—Epirubicin—testicular cancer	2.58e-05	0.000357	CcSEcCtD
Busulfan—Dizziness—Ifosfamide—testicular cancer	2.57e-05	0.000357	CcSEcCtD
Busulfan—Pharyngitis—Methotrexate—testicular cancer	2.57e-05	0.000357	CcSEcCtD
Busulfan—Urinary tract disorder—Methotrexate—testicular cancer	2.56e-05	0.000355	CcSEcCtD
Busulfan—Hepatobiliary disease—Epirubicin—testicular cancer	2.55e-05	0.000355	CcSEcCtD
Busulfan—Weight increased—Doxorubicin—testicular cancer	2.55e-05	0.000354	CcSEcCtD
Busulfan—Epistaxis—Epirubicin—testicular cancer	2.55e-05	0.000354	CcSEcCtD
Busulfan—Urethral disorder—Methotrexate—testicular cancer	2.54e-05	0.000353	CcSEcCtD
Busulfan—Weight decreased—Doxorubicin—testicular cancer	2.54e-05	0.000352	CcSEcCtD
Busulfan—Sinusitis—Epirubicin—testicular cancer	2.53e-05	0.000352	CcSEcCtD
Busulfan—Feeling abnormal—Etoposide—testicular cancer	2.53e-05	0.000351	CcSEcCtD
Busulfan—Hyperglycaemia—Doxorubicin—testicular cancer	2.53e-05	0.000351	CcSEcCtD
Busulfan—Nausea—Dactinomycin—testicular cancer	2.52e-05	0.00035	CcSEcCtD
Busulfan—Agranulocytosis—Epirubicin—testicular cancer	2.52e-05	0.00035	CcSEcCtD
Busulfan—Pneumonia—Doxorubicin—testicular cancer	2.51e-05	0.000349	CcSEcCtD
Busulfan—Gastrointestinal pain—Etoposide—testicular cancer	2.51e-05	0.000349	CcSEcCtD
Busulfan—Infestation NOS—Doxorubicin—testicular cancer	2.5e-05	0.000347	CcSEcCtD
Busulfan—Infestation—Doxorubicin—testicular cancer	2.5e-05	0.000347	CcSEcCtD
Busulfan—Vomiting—Ifosfamide—testicular cancer	2.47e-05	0.000343	CcSEcCtD
Busulfan—Hypersensitivity—Cisplatin—testicular cancer	2.47e-05	0.000343	CcSEcCtD
Busulfan—Bradycardia—Epirubicin—testicular cancer	2.47e-05	0.000343	CcSEcCtD
Busulfan—Renal failure—Doxorubicin—testicular cancer	2.46e-05	0.000341	CcSEcCtD
Busulfan—Rash—Ifosfamide—testicular cancer	2.45e-05	0.000341	CcSEcCtD
Busulfan—Dermatitis—Ifosfamide—testicular cancer	2.45e-05	0.00034	CcSEcCtD
Busulfan—Erythema multiforme—Methotrexate—testicular cancer	2.45e-05	0.00034	CcSEcCtD
Busulfan—Urticaria—Etoposide—testicular cancer	2.44e-05	0.000339	CcSEcCtD
Busulfan—Haemoglobin—Epirubicin—testicular cancer	2.44e-05	0.000338	CcSEcCtD
Busulfan—Jaundice—Doxorubicin—testicular cancer	2.44e-05	0.000338	CcSEcCtD
Busulfan—Stomatitis—Doxorubicin—testicular cancer	2.44e-05	0.000338	CcSEcCtD
Busulfan—Rhinitis—Epirubicin—testicular cancer	2.43e-05	0.000337	CcSEcCtD
Busulfan—Abdominal pain—Etoposide—testicular cancer	2.43e-05	0.000337	CcSEcCtD
Busulfan—Body temperature increased—Etoposide—testicular cancer	2.43e-05	0.000337	CcSEcCtD
Busulfan—Haemorrhage—Epirubicin—testicular cancer	2.43e-05	0.000337	CcSEcCtD
Busulfan—Eye disorder—Methotrexate—testicular cancer	2.42e-05	0.000336	CcSEcCtD
Busulfan—Asthenia—Cisplatin—testicular cancer	2.41e-05	0.000334	CcSEcCtD
Busulfan—Pharyngitis—Epirubicin—testicular cancer	2.41e-05	0.000334	CcSEcCtD
Busulfan—Cardiac disorder—Methotrexate—testicular cancer	2.41e-05	0.000334	CcSEcCtD
Busulfan—Urinary tract disorder—Epirubicin—testicular cancer	2.39e-05	0.000332	CcSEcCtD
Busulfan—Haematuria—Doxorubicin—testicular cancer	2.38e-05	0.000331	CcSEcCtD
Busulfan—Connective tissue disorder—Epirubicin—testicular cancer	2.38e-05	0.000331	CcSEcCtD
Busulfan—Urethral disorder—Epirubicin—testicular cancer	2.38e-05	0.00033	CcSEcCtD
Busulfan—Hepatobiliary disease—Doxorubicin—testicular cancer	2.36e-05	0.000328	CcSEcCtD
Busulfan—Epistaxis—Doxorubicin—testicular cancer	2.36e-05	0.000327	CcSEcCtD
Busulfan—Angiopathy—Methotrexate—testicular cancer	2.35e-05	0.000326	CcSEcCtD
Busulfan—Sinusitis—Doxorubicin—testicular cancer	2.35e-05	0.000325	CcSEcCtD
Busulfan—Immune system disorder—Methotrexate—testicular cancer	2.34e-05	0.000325	CcSEcCtD
Busulfan—Mediastinal disorder—Methotrexate—testicular cancer	2.34e-05	0.000324	CcSEcCtD
Busulfan—Agranulocytosis—Doxorubicin—testicular cancer	2.33e-05	0.000324	CcSEcCtD
Busulfan—Chills—Methotrexate—testicular cancer	2.33e-05	0.000323	CcSEcCtD
Busulfan—Nausea—Ifosfamide—testicular cancer	2.31e-05	0.000321	CcSEcCtD
Busulfan—Diarrhoea—Cisplatin—testicular cancer	2.3e-05	0.000319	CcSEcCtD
Busulfan—Erythema multiforme—Epirubicin—testicular cancer	2.29e-05	0.000318	CcSEcCtD
Busulfan—Alopecia—Methotrexate—testicular cancer	2.29e-05	0.000318	CcSEcCtD
Busulfan—Bradycardia—Doxorubicin—testicular cancer	2.28e-05	0.000317	CcSEcCtD
Busulfan—Mental disorder—Methotrexate—testicular cancer	2.27e-05	0.000315	CcSEcCtD
Busulfan—Eye disorder—Epirubicin—testicular cancer	2.27e-05	0.000314	CcSEcCtD
Busulfan—Hypersensitivity—Etoposide—testicular cancer	2.26e-05	0.000314	CcSEcCtD
Busulfan—Erythema—Methotrexate—testicular cancer	2.26e-05	0.000313	CcSEcCtD
Busulfan—Malnutrition—Methotrexate—testicular cancer	2.26e-05	0.000313	CcSEcCtD
Busulfan—Haemoglobin—Doxorubicin—testicular cancer	2.26e-05	0.000313	CcSEcCtD
Busulfan—Flushing—Epirubicin—testicular cancer	2.25e-05	0.000312	CcSEcCtD
Busulfan—Cardiac disorder—Epirubicin—testicular cancer	2.25e-05	0.000312	CcSEcCtD
Busulfan—Rhinitis—Doxorubicin—testicular cancer	2.25e-05	0.000312	CcSEcCtD
Busulfan—Haemorrhage—Doxorubicin—testicular cancer	2.24e-05	0.000311	CcSEcCtD
Busulfan—Pharyngitis—Doxorubicin—testicular cancer	2.23e-05	0.000309	CcSEcCtD
Busulfan—Urinary tract disorder—Doxorubicin—testicular cancer	2.22e-05	0.000308	CcSEcCtD
Busulfan—Asthenia—Etoposide—testicular cancer	2.21e-05	0.000306	CcSEcCtD
Busulfan—Connective tissue disorder—Doxorubicin—testicular cancer	2.21e-05	0.000306	CcSEcCtD
Busulfan—Angiopathy—Epirubicin—testicular cancer	2.2e-05	0.000305	CcSEcCtD
Busulfan—Urethral disorder—Doxorubicin—testicular cancer	2.2e-05	0.000305	CcSEcCtD
Busulfan—Immune system disorder—Epirubicin—testicular cancer	2.19e-05	0.000304	CcSEcCtD
Busulfan—Mediastinal disorder—Epirubicin—testicular cancer	2.19e-05	0.000303	CcSEcCtD
Busulfan—Back pain—Methotrexate—testicular cancer	2.18e-05	0.000303	CcSEcCtD
Busulfan—Chills—Epirubicin—testicular cancer	2.18e-05	0.000302	CcSEcCtD
Busulfan—Pruritus—Etoposide—testicular cancer	2.17e-05	0.000302	CcSEcCtD
Busulfan—Arrhythmia—Epirubicin—testicular cancer	2.17e-05	0.000301	CcSEcCtD
Busulfan—Alopecia—Epirubicin—testicular cancer	2.14e-05	0.000297	CcSEcCtD
Busulfan—Vomiting—Cisplatin—testicular cancer	2.13e-05	0.000296	CcSEcCtD
Busulfan—Mental disorder—Epirubicin—testicular cancer	2.12e-05	0.000295	CcSEcCtD
Busulfan—Erythema multiforme—Doxorubicin—testicular cancer	2.12e-05	0.000294	CcSEcCtD
Busulfan—Rash—Cisplatin—testicular cancer	2.12e-05	0.000294	CcSEcCtD
Busulfan—Dermatitis—Cisplatin—testicular cancer	2.11e-05	0.000293	CcSEcCtD
Busulfan—Erythema—Epirubicin—testicular cancer	2.11e-05	0.000293	CcSEcCtD
Busulfan—Malnutrition—Epirubicin—testicular cancer	2.11e-05	0.000293	CcSEcCtD
Busulfan—Diarrhoea—Etoposide—testicular cancer	2.1e-05	0.000292	CcSEcCtD
Busulfan—Eye disorder—Doxorubicin—testicular cancer	2.1e-05	0.000291	CcSEcCtD
Busulfan—Anaemia—Methotrexate—testicular cancer	2.08e-05	0.000289	CcSEcCtD
Busulfan—Flushing—Doxorubicin—testicular cancer	2.08e-05	0.000289	CcSEcCtD
Busulfan—Cardiac disorder—Doxorubicin—testicular cancer	2.08e-05	0.000289	CcSEcCtD
Busulfan—Tension—Epirubicin—testicular cancer	2.07e-05	0.000287	CcSEcCtD
Busulfan—Nervousness—Epirubicin—testicular cancer	2.05e-05	0.000285	CcSEcCtD
Busulfan—Back pain—Epirubicin—testicular cancer	2.04e-05	0.000283	CcSEcCtD
Busulfan—Angiopathy—Doxorubicin—testicular cancer	2.04e-05	0.000283	CcSEcCtD
Busulfan—Dizziness—Etoposide—testicular cancer	2.03e-05	0.000282	CcSEcCtD
Busulfan—Immune system disorder—Doxorubicin—testicular cancer	2.03e-05	0.000281	CcSEcCtD
Busulfan—Mediastinal disorder—Doxorubicin—testicular cancer	2.02e-05	0.000281	CcSEcCtD
Busulfan—Leukopenia—Methotrexate—testicular cancer	2.02e-05	0.00028	CcSEcCtD
Busulfan—Chills—Doxorubicin—testicular cancer	2.01e-05	0.000279	CcSEcCtD
Busulfan—Arrhythmia—Doxorubicin—testicular cancer	2e-05	0.000278	CcSEcCtD
Busulfan—Nausea—Cisplatin—testicular cancer	1.99e-05	0.000277	CcSEcCtD
Busulfan—Alopecia—Doxorubicin—testicular cancer	1.98e-05	0.000275	CcSEcCtD
Busulfan—Cough—Methotrexate—testicular cancer	1.97e-05	0.000273	CcSEcCtD
Busulfan—Mental disorder—Doxorubicin—testicular cancer	1.97e-05	0.000273	CcSEcCtD
Busulfan—Convulsion—Methotrexate—testicular cancer	1.95e-05	0.000271	CcSEcCtD
Busulfan—Vomiting—Etoposide—testicular cancer	1.95e-05	0.000271	CcSEcCtD
Busulfan—Malnutrition—Doxorubicin—testicular cancer	1.95e-05	0.000271	CcSEcCtD
Busulfan—Erythema—Doxorubicin—testicular cancer	1.95e-05	0.000271	CcSEcCtD
Busulfan—Anaemia—Epirubicin—testicular cancer	1.95e-05	0.000271	CcSEcCtD
Busulfan—Agitation—Epirubicin—testicular cancer	1.94e-05	0.000269	CcSEcCtD
Busulfan—Rash—Etoposide—testicular cancer	1.94e-05	0.000269	CcSEcCtD
Busulfan—Dermatitis—Etoposide—testicular cancer	1.94e-05	0.000269	CcSEcCtD
Busulfan—Headache—Etoposide—testicular cancer	1.93e-05	0.000267	CcSEcCtD
Busulfan—Arthralgia—Methotrexate—testicular cancer	1.92e-05	0.000267	CcSEcCtD
Busulfan—Chest pain—Methotrexate—testicular cancer	1.92e-05	0.000267	CcSEcCtD
Busulfan—Myalgia—Methotrexate—testicular cancer	1.92e-05	0.000267	CcSEcCtD
Busulfan—Tension—Doxorubicin—testicular cancer	1.92e-05	0.000266	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	1.91e-05	0.000265	CcSEcCtD
Busulfan—Nervousness—Doxorubicin—testicular cancer	1.9e-05	0.000263	CcSEcCtD
Busulfan—Leukopenia—Epirubicin—testicular cancer	1.89e-05	0.000262	CcSEcCtD
Busulfan—Back pain—Doxorubicin—testicular cancer	1.89e-05	0.000262	CcSEcCtD
Busulfan—Confusional state—Methotrexate—testicular cancer	1.86e-05	0.000258	CcSEcCtD
Busulfan—Cough—Epirubicin—testicular cancer	1.84e-05	0.000256	CcSEcCtD
Busulfan—Convulsion—Epirubicin—testicular cancer	1.83e-05	0.000254	CcSEcCtD
Busulfan—Infection—Methotrexate—testicular cancer	1.83e-05	0.000254	CcSEcCtD
Busulfan—Nausea—Etoposide—testicular cancer	1.83e-05	0.000253	CcSEcCtD
Busulfan—Hypertension—Epirubicin—testicular cancer	1.82e-05	0.000253	CcSEcCtD
Busulfan—Nervous system disorder—Methotrexate—testicular cancer	1.81e-05	0.000251	CcSEcCtD
Busulfan—Anaemia—Doxorubicin—testicular cancer	1.81e-05	0.000251	CcSEcCtD
Busulfan—Thrombocytopenia—Methotrexate—testicular cancer	1.8e-05	0.00025	CcSEcCtD
Busulfan—Myalgia—Epirubicin—testicular cancer	1.8e-05	0.000249	CcSEcCtD
Busulfan—Chest pain—Epirubicin—testicular cancer	1.8e-05	0.000249	CcSEcCtD
Busulfan—Arthralgia—Epirubicin—testicular cancer	1.8e-05	0.000249	CcSEcCtD
Busulfan—Agitation—Doxorubicin—testicular cancer	1.8e-05	0.000249	CcSEcCtD
Busulfan—Anxiety—Epirubicin—testicular cancer	1.79e-05	0.000249	CcSEcCtD
Busulfan—Skin disorder—Methotrexate—testicular cancer	1.79e-05	0.000248	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	1.78e-05	0.000248	CcSEcCtD
Busulfan—Dry mouth—Epirubicin—testicular cancer	1.76e-05	0.000244	CcSEcCtD
Busulfan—Anorexia—Methotrexate—testicular cancer	1.75e-05	0.000244	CcSEcCtD
Busulfan—Leukopenia—Doxorubicin—testicular cancer	1.75e-05	0.000243	CcSEcCtD
Busulfan—Confusional state—Epirubicin—testicular cancer	1.74e-05	0.000241	CcSEcCtD
Busulfan—Oedema—Epirubicin—testicular cancer	1.72e-05	0.000239	CcSEcCtD
Busulfan—Hypotension—Methotrexate—testicular cancer	1.72e-05	0.000239	CcSEcCtD
Busulfan—Infection—Epirubicin—testicular cancer	1.71e-05	0.000238	CcSEcCtD
Busulfan—Cough—Doxorubicin—testicular cancer	1.7e-05	0.000237	CcSEcCtD
Busulfan—Convulsion—Doxorubicin—testicular cancer	1.69e-05	0.000235	CcSEcCtD
Busulfan—Nervous system disorder—Epirubicin—testicular cancer	1.69e-05	0.000234	CcSEcCtD
Busulfan—Thrombocytopenia—Epirubicin—testicular cancer	1.69e-05	0.000234	CcSEcCtD
Busulfan—Hypertension—Doxorubicin—testicular cancer	1.69e-05	0.000234	CcSEcCtD
Busulfan—Tachycardia—Epirubicin—testicular cancer	1.68e-05	0.000233	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Methotrexate—testicular cancer	1.68e-05	0.000233	CcSEcCtD
Busulfan—Skin disorder—Epirubicin—testicular cancer	1.67e-05	0.000232	CcSEcCtD
Busulfan—Insomnia—Methotrexate—testicular cancer	1.67e-05	0.000231	CcSEcCtD
Busulfan—Myalgia—Doxorubicin—testicular cancer	1.66e-05	0.000231	CcSEcCtD
Busulfan—Arthralgia—Doxorubicin—testicular cancer	1.66e-05	0.000231	CcSEcCtD
Busulfan—Chest pain—Doxorubicin—testicular cancer	1.66e-05	0.000231	CcSEcCtD
Busulfan—Anxiety—Doxorubicin—testicular cancer	1.66e-05	0.00023	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	1.65e-05	0.000229	CcSEcCtD
Busulfan—Anorexia—Epirubicin—testicular cancer	1.64e-05	0.000228	CcSEcCtD
Busulfan—Dyspnoea—Methotrexate—testicular cancer	1.64e-05	0.000228	CcSEcCtD
Busulfan—Somnolence—Methotrexate—testicular cancer	1.64e-05	0.000227	CcSEcCtD
Busulfan—Dry mouth—Doxorubicin—testicular cancer	1.63e-05	0.000226	CcSEcCtD
Busulfan—Dyspepsia—Methotrexate—testicular cancer	1.62e-05	0.000225	CcSEcCtD
Busulfan—Hypotension—Epirubicin—testicular cancer	1.61e-05	0.000223	CcSEcCtD
Busulfan—Confusional state—Doxorubicin—testicular cancer	1.61e-05	0.000223	CcSEcCtD
Busulfan—Decreased appetite—Methotrexate—testicular cancer	1.6e-05	0.000222	CcSEcCtD
Busulfan—Oedema—Doxorubicin—testicular cancer	1.59e-05	0.000221	CcSEcCtD
Busulfan—Gastrointestinal disorder—Methotrexate—testicular cancer	1.59e-05	0.000221	CcSEcCtD
Busulfan—Fatigue—Methotrexate—testicular cancer	1.59e-05	0.00022	CcSEcCtD
Busulfan—Infection—Doxorubicin—testicular cancer	1.58e-05	0.00022	CcSEcCtD
Busulfan—Pain—Methotrexate—testicular cancer	1.57e-05	0.000218	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Epirubicin—testicular cancer	1.57e-05	0.000218	CcSEcCtD
Busulfan—Nervous system disorder—Doxorubicin—testicular cancer	1.56e-05	0.000217	CcSEcCtD
Busulfan—Thrombocytopenia—Doxorubicin—testicular cancer	1.56e-05	0.000217	CcSEcCtD
Busulfan—Insomnia—Epirubicin—testicular cancer	1.56e-05	0.000216	CcSEcCtD
Busulfan—Tachycardia—Doxorubicin—testicular cancer	1.56e-05	0.000216	CcSEcCtD
Busulfan—Skin disorder—Doxorubicin—testicular cancer	1.55e-05	0.000215	CcSEcCtD
Busulfan—Dyspnoea—Epirubicin—testicular cancer	1.54e-05	0.000213	CcSEcCtD
Busulfan—Somnolence—Epirubicin—testicular cancer	1.53e-05	0.000213	CcSEcCtD
Busulfan—Anorexia—Doxorubicin—testicular cancer	1.52e-05	0.000211	CcSEcCtD
Busulfan—Feeling abnormal—Methotrexate—testicular cancer	1.52e-05	0.000211	CcSEcCtD
Busulfan—Dyspepsia—Epirubicin—testicular cancer	1.52e-05	0.00021	CcSEcCtD
Busulfan—Gastrointestinal pain—Methotrexate—testicular cancer	1.51e-05	0.000209	CcSEcCtD
Busulfan—Decreased appetite—Epirubicin—testicular cancer	1.5e-05	0.000208	CcSEcCtD
Busulfan—Hypotension—Doxorubicin—testicular cancer	1.49e-05	0.000207	CcSEcCtD
Busulfan—Gastrointestinal disorder—Epirubicin—testicular cancer	1.49e-05	0.000206	CcSEcCtD
Busulfan—Fatigue—Epirubicin—testicular cancer	1.49e-05	0.000206	CcSEcCtD
Busulfan—Pain—Epirubicin—testicular cancer	1.47e-05	0.000204	CcSEcCtD
Busulfan—Constipation—Epirubicin—testicular cancer	1.47e-05	0.000204	CcSEcCtD
Busulfan—Urticaria—Methotrexate—testicular cancer	1.46e-05	0.000203	CcSEcCtD
Busulfan—Abdominal pain—Methotrexate—testicular cancer	1.46e-05	0.000202	CcSEcCtD
Busulfan—Body temperature increased—Methotrexate—testicular cancer	1.46e-05	0.000202	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Doxorubicin—testicular cancer	1.45e-05	0.000202	CcSEcCtD
Busulfan—Insomnia—Doxorubicin—testicular cancer	1.44e-05	0.0002	CcSEcCtD
Busulfan—Dyspnoea—Doxorubicin—testicular cancer	1.42e-05	0.000197	CcSEcCtD
Busulfan—Feeling abnormal—Epirubicin—testicular cancer	1.42e-05	0.000197	CcSEcCtD
Busulfan—Somnolence—Doxorubicin—testicular cancer	1.42e-05	0.000197	CcSEcCtD
Busulfan—Gastrointestinal pain—Epirubicin—testicular cancer	1.41e-05	0.000196	CcSEcCtD
Busulfan—Dyspepsia—Doxorubicin—testicular cancer	1.4e-05	0.000195	CcSEcCtD
Busulfan—Decreased appetite—Doxorubicin—testicular cancer	1.39e-05	0.000192	CcSEcCtD
Busulfan—Gastrointestinal disorder—Doxorubicin—testicular cancer	1.38e-05	0.000191	CcSEcCtD
Busulfan—Fatigue—Doxorubicin—testicular cancer	1.37e-05	0.000191	CcSEcCtD
Busulfan—Urticaria—Epirubicin—testicular cancer	1.37e-05	0.00019	CcSEcCtD
Busulfan—Pain—Doxorubicin—testicular cancer	1.36e-05	0.000189	CcSEcCtD
Busulfan—Constipation—Doxorubicin—testicular cancer	1.36e-05	0.000189	CcSEcCtD
Busulfan—Body temperature increased—Epirubicin—testicular cancer	1.36e-05	0.000189	CcSEcCtD
Busulfan—Abdominal pain—Epirubicin—testicular cancer	1.36e-05	0.000189	CcSEcCtD
Busulfan—Hypersensitivity—Methotrexate—testicular cancer	1.36e-05	0.000188	CcSEcCtD
Busulfan—Asthenia—Methotrexate—testicular cancer	1.32e-05	0.000183	CcSEcCtD
Busulfan—Feeling abnormal—Doxorubicin—testicular cancer	1.31e-05	0.000182	CcSEcCtD
Busulfan—Gastrointestinal pain—Doxorubicin—testicular cancer	1.3e-05	0.000181	CcSEcCtD
Busulfan—Pruritus—Methotrexate—testicular cancer	1.3e-05	0.000181	CcSEcCtD
Busulfan—Hypersensitivity—Epirubicin—testicular cancer	1.27e-05	0.000176	CcSEcCtD
Busulfan—Urticaria—Doxorubicin—testicular cancer	1.27e-05	0.000176	CcSEcCtD
Busulfan—Abdominal pain—Doxorubicin—testicular cancer	1.26e-05	0.000175	CcSEcCtD
Busulfan—Body temperature increased—Doxorubicin—testicular cancer	1.26e-05	0.000175	CcSEcCtD
Busulfan—Diarrhoea—Methotrexate—testicular cancer	1.26e-05	0.000175	CcSEcCtD
Busulfan—Asthenia—Epirubicin—testicular cancer	1.24e-05	0.000172	CcSEcCtD
Busulfan—Pruritus—Epirubicin—testicular cancer	1.22e-05	0.000169	CcSEcCtD
Busulfan—Dizziness—Methotrexate—testicular cancer	1.22e-05	0.000169	CcSEcCtD
Busulfan—Diarrhoea—Epirubicin—testicular cancer	1.18e-05	0.000164	CcSEcCtD
Busulfan—Hypersensitivity—Doxorubicin—testicular cancer	1.17e-05	0.000163	CcSEcCtD
Busulfan—Vomiting—Methotrexate—testicular cancer	1.17e-05	0.000162	CcSEcCtD
Busulfan—Rash—Methotrexate—testicular cancer	1.16e-05	0.000161	CcSEcCtD
Busulfan—Dermatitis—Methotrexate—testicular cancer	1.16e-05	0.000161	CcSEcCtD
Busulfan—Headache—Methotrexate—testicular cancer	1.15e-05	0.00016	CcSEcCtD
Busulfan—Asthenia—Doxorubicin—testicular cancer	1.14e-05	0.000159	CcSEcCtD
Busulfan—Dizziness—Epirubicin—testicular cancer	1.14e-05	0.000158	CcSEcCtD
Busulfan—Pruritus—Doxorubicin—testicular cancer	1.13e-05	0.000157	CcSEcCtD
Busulfan—Vomiting—Epirubicin—testicular cancer	1.1e-05	0.000152	CcSEcCtD
Busulfan—Nausea—Methotrexate—testicular cancer	1.09e-05	0.000152	CcSEcCtD
Busulfan—Diarrhoea—Doxorubicin—testicular cancer	1.09e-05	0.000151	CcSEcCtD
Busulfan—Rash—Epirubicin—testicular cancer	1.09e-05	0.000151	CcSEcCtD
Busulfan—Dermatitis—Epirubicin—testicular cancer	1.09e-05	0.000151	CcSEcCtD
Busulfan—Headache—Epirubicin—testicular cancer	1.08e-05	0.00015	CcSEcCtD
Busulfan—Dizziness—Doxorubicin—testicular cancer	1.05e-05	0.000146	CcSEcCtD
Busulfan—Nausea—Epirubicin—testicular cancer	1.02e-05	0.000142	CcSEcCtD
Busulfan—Vomiting—Doxorubicin—testicular cancer	1.01e-05	0.000141	CcSEcCtD
Busulfan—Rash—Doxorubicin—testicular cancer	1.01e-05	0.000139	CcSEcCtD
Busulfan—Dermatitis—Doxorubicin—testicular cancer	1e-05	0.000139	CcSEcCtD
Busulfan—Headache—Doxorubicin—testicular cancer	9.99e-06	0.000139	CcSEcCtD
Busulfan—Nausea—Doxorubicin—testicular cancer	9.47e-06	0.000131	CcSEcCtD
Busulfan—CYP3A4—Metabolism—HPGDS—testicular cancer	5.68e-06	0.000305	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—STK11—testicular cancer	4.13e-06	0.000222	CbGpPWpGaD
